Interpretation and Use of Natriuretic Peptides in Non-Congestive Heart Failure Settings

키워드

참고문헌 (112)

1. Swedberg K, "Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology", Eur Heart J, 26, pp.1115~1140 (2005)
2. Januzzi JL, "NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study", Eur Heart J, 27, pp.330~337 (2006)
3. Kisch B, "Electron microscopy of the atrium of the heart", I. Guinea pig. Exp Med Surg, 14, pp.99~112 (1956)
4. De Bold AJ, "Heart atria granularity effects of changes in waterelectrolyte balance", Proc Soc Exp Biol Med, 161, pp.508~511 (1979)
5. Iwanaga Y, "B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure", J Am Coll Cardiol, 47, pp.742~748 (2006)
6. Burjonroppa SC, "Cancer patients with markedly elevated B-type natriuretic peptide may not have volume overload", Am J Clin Oncol, 30, pp.287~293 (2007)
7. Schrier RW, "Hormones and hemodynamics in heart failure", N Engl J Med, 341, pp.577~585 (1999)
8. Young JB, "Testing for B-type natriuretic peptide in the diagnosis and assessment of heart failure: what are the nuances?", Cleve Clin J Med, 71, pp.S1~17 (2004)
9. Hawkridge AM, "Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure", Proc Natl Acad Sci U S A, 102, pp.17442~17447 (2005)
10. Omland T, "Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure", Crit Care Med, 36, pp.S17~27 (2008)
11. Prontera C, "Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study" (2009), Clin Chem Lab Med 2009
12. Chen AA, "NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy", Eur Heart J, 27, pp.839~845 (2006)
13. Vanderheyden M, "Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with", without left ventricular systolic dysfunction, 2006, pp.39, 640~645
14. Brown A, "Could BNP screening of acute chest pain cases lead to safe earlier discharge of patients with non-cardiac causes? A pilot study", QJM, 100, pp.755~761 (2007)
15. Fukuta H, "Anemia is an independent predictor for elevated plasma levels of natriuretic peptides in patients undergoing cardiac catheterization for coronary artery disease", Circ J, 72, pp.212~217 (2008)
16. Ogawa A, "Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome", Circ J, 70, pp.1372~1378 (2006)
17. Sinclair H, "Predicting outcome in patients with acute coronary syndrome: evaluation of B-type natriuretic peptide and the global registry of acute coronary events (GRACE) risk score", Scott Med J, 52, pp.8~13 (2007)
18. Günes Y, "Value of brain natriuretic peptide after acute myocardial infarction", Anadolu Kardiyol Derg, 8, pp.182~187 (2008)
19. Kwan G, "Short-term serial sampling of natriuretic peptides in patients presenting with chest pain", J Am Coll Cardiol, 49, pp.1186~1192 (2007)
20. Palazzuoli A, "Osteoprotegerin and B-type natriuretic peptide in non-ST elevation acute coronary syndromes: relation to coronary artery narrowing and plaques number", Clin Chim Acta, 391, pp.74~79 (2008)
21. Sun T, "Prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes", Arch Med Res, 37, pp.502~505 (2006)
22. Fonarow GC, "Usefulness of B-Type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE", Am J Cardiol, 101, pp.231~237 (2008)
23. Tello-Montoliu A, "A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels", J Intern Med, 262, pp.651~658 (2007)
24. Morrow DA, "Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease", JAMA, 294, pp.2866~2871 (2005)
25. Yildirir A, "Value of peri-procedural B-type natriuretic peptide levels in predicting cardiac events after elective percutaneous coronary intervention", Acta Cardiol, 63, pp.47~52 (2008)
26. Lo Mauro R, "B-type natriuretic peptide as a marker of asymptomatic re-stenosis after coronary implantation of a paclitaxeleluting stent", J Cardiovasc Med (Hagerstown), 8, pp.1020~1023 (2007)
27. Elíasdóttir SB, "Brain natriuretic peptide is a good predictor for outcome in cardiac surgery", Acta Anaesthesiol Scand, 52, pp.182~187 (2008)
28. Turk T, "Plasma brain natriuretic peptide after isolated on-pump coronary artery bypass grafting: prediction of postoperative adverse outcomes", Heart Surg Forum, 11, pp.E84~89 (2008)
29. Sarzi Braga S, "Plasma B-type natriuretic peptide predicts atrial fibrillation during rehabilitation after cardiac surgery", Eur J Cardiovasc Prev Rehabil, 15, pp.460~466 (2008)
30. Shaw SM, "Does brain natriuretic peptide interact with the immune system after cardiac transplantation?", Transplantation, 84, pp.1377~1381 (2007)
31. Rossano JW, "B-type Natriuretic peptide is a sensitive screening test for acute rejection in pediatric heart transplant patients", J Heart Lung Transplant, 27, pp.649~654 (2008)
32. Martínez-Dolz L, "Prognostic relationship between two serial determinations of B-type natriuretic peptide and mediumlong-term events in heart transplantation", J Heart Lung Transplant, 27, pp.735~740 (2008)
33. Heise G, "Biomarker responses during mid-term mechanical cardiac support in children", J Heart Lung Transplant, 27, pp.150~157 (2008)
34. Pruszczyk P, "N-terminal pro-brain natriuretic peptide as an indicator of right ventricular dysfunction", J Card Fail, 11, pp.S65~69 (2005)
35. Alonso-Martínez JL, "Nterminal pro-B-type natriuretic peptide predicts the burden of pulmonary embolism", Am J Med Sci, 337, pp.88~92 (2009)
36. Yardan T, "B-type natriuretic peptide as an indicator of right ventricular dysfunction in acute pulmonary embolism", Int J Clin Pract, 62, pp.1177~1182 (2008)
37. Binder L, "N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism", Circulation, 112, pp.1573~1579 (2005)
38. Enea I, "Biohumoral markers and right ventricular dysfunction in acute pulmonary embolism: the answer to thrombolytic therapy", Ital Heart J Suppl, 5, pp.29~35 (2004)
39. Logeart D, "Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism", Intensive Care Med, 33, pp.286~292 (2007)
40. Yap LB, "Natriuretic peptides, respiratory disease, and the right heart", Chest, 126, pp.1330~1336 (2004)
41. Yano S, "The study of pulmonary hypertension and plasma BNP values in respiratory diseases", Nihon Kokyuki Gakkai Zasshi, 44, pp.99~103 (2006)
42. Andreassen AK, "N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension", Am J Cardiol, 98, pp.525~529 (2006)
43. Yap LB, "Natriuretic peptides, respiratory disease, and the right heart", Chest, 126, pp.1330~1336 (2004)
44. Kanat F, "Diuretics, plasma brain natriuretic peptide and chronic obstructive pulmonary disease", Neth J Med, 65, pp.296~300 (2007)
45. Stolz D, "Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD", Chest, 133, pp.1088~1094 (2008)
46. Chien JY, "Changes in B-type natriuretic peptide improve weaning outcome predicted by spontaneous breathing trial", Crit Care Med, 36, pp.1421~1426 (2008)
47. Moe GW, "Canadian Multicenter Improved Management of Patients With Congestive Heart Failure (IMPROVE-CHF) Study Investigators. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study", Circulation, 115, pp.3103~3110 (2007)
48. Iltumur K, "N-terminal proBNP plasma levels correlate with severity of mitral stenosis", J Heart Valve Dis, 14, pp.735~741 (2005)
49. Arat-Ozkan A, "Serum N-terminal pro-BNP levels correlate with symptoms and echocardiographic findings in patients with mitral stenosis", Echocardiography, 22, pp.473~478 (2005)
50. Cemri M, "Relationship between N-terminal pro-B type natriuretic peptide and extensive echocardiographic parameters in mild to moderate aortic stenosis", J Postgrad Med, 54, pp.12~16 (2008)
51. Della Corte A, "Preoperative, postoperative and 1-year follow-up N-terminal pro-B-type natriuretic peptide levels in severe chronic aortic regurgitation: correlations with echocardiographic findings", Interact Cardiovasc Thorac Surg, 7, pp.419~424 (2008)
52. Moura LM, "New cardiovascular biomarkers:clinical implications in patients with valvular heart disease", Expert Rev Cardiovasc Ther, 6, pp.945~954 (2008)
53. Iversen K, "Heart murmur and N-terminal pro-brain natriuretic peptide as predictors of death in 2977 consecutive hospitalized patients", Am J Med Sci, 335, pp.444~450 (2008)
54. Therkelsen SK, "ANP and BNP in atrial fibrillation before and after cardioversion--and their relationship to cardiac volume and function", Int J Cardiol, 127, pp.396~399 (2008)
55. Sacher F, "Chronic atrial fibrillation ablation impact on endocrine and mechanical cardiac functions", Eur Heart J, 29, pp.1290~1295 (2008)
56. Tveit A, "Candesartan, NT-proBNP and recurrence of atrial fib-rillation after electrical cardioversion", Int J Cardiol, 131, pp.234~239 (2009)
57. Yamada T, "Plasma brain natriuretic peptide level after hybrid therapy with pulmonary vein isolation and antiarrhythmic drugs for atrial fibrillation", Int Heart J, 49, pp.143~151 (2008)
58. Ahlsson A, "Atrial function after epicardial microwave ablation in patients with atrial fibrillation", Scand Cardiovasc J, 42, pp.192~201 (2008)
59. Magioncalda A, "The utility of assaying the N-terminal of brain natriuretic peptide precursor (NT pro-BNP) to predict the clinical outcome in patients with supraventricular tachyarrhythmias observed and treated in the emergency room", Recenti Prog Med, 99, pp.141~145 (2008)
60. Kawanishi Y, "Effect of left ventricular dyssynchrony on plasma B-type natriuretic peptide levels in patients with long-term right ventricular apical pacing", Int Heart J, 49, pp.165~173 (2008)
61. Koch A, "Plasma levels of B-type natriuretic peptide in children and adolescents with high degree atrioventricular block", Int J Cardiol, 134, pp.429~430 (2009)
62. Ogawa T, "Angiotensin II receptor antagonism reverts the selective cardiac BNP upregulation and secretion observed in myocarditis", Am J Physiol Heart Circ Physiol, 294, pp.H2596~2603 (2008)
63. Grabowski M, "Diagnostic value of BNP in suspected perimyocarditis--a preliminary report", Kardiol Pol, 61, pp.451~458 (2004)
64. Kahveci G, "Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis", Am J Cardiol, 99, pp.1429~1433 (2007)
65. Bayram E, "The role of adrenomedullin and brain natriuretic peptide levels in acute rheumatic fever in adults", Anadolu Kardiyol Derg, 8, pp.188~191 (2008)
66. Zhang QY, "Change in plasma Nterminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice", Zhonghua Er Ke Za Zhi, 44, pp.886~890 (2006)
67. Leya FS, "The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy", J Am Coll Cardiol, 45, pp.1900~1902 (2005)
68. Babuin L, "Brain natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy", J Am Coll Cardiol, 47, pp.1489~1491 (2006)
69. Pfister R, "NTpro-BNP for differential diagnosis in patients with syncope", Int J Cardiol, 133, pp.51~54 (2009)
70. Usui Y, "Plasma B-type natriuretic peptide level is associated with left ventricular hypertrophy among obstructive sleep apnoea patients", J Hypertens, 26, pp.117~123 (2008)
71. Ybarra J, "Aminoterminal pro-brain natriuretic peptide (NT-proBNP) and sleep-disordered breathing in morbidly obese females: a cross-sectional study", Diab Vasc Dis Res, 5, pp.19~24 (2008)
72. Seki S, "Clinical significance of B-type natriuretic Peptide in the assessment of untreated hypertension", Circ J, 72, pp.770~777 (2008)
73. Sbarouni E, "D-dimer and BNP levels in acute aortic dissection", Int J Cardiol, 122, pp.170~172 (2007)
74. Czernik C, "B-type natriuretic peptide to predict ductus intervention in infants < 28 weeks", Pediatr Res, 64, pp.286~290 (2008)
75. Farombi-Oghuvbu I, "N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus", Arch Dis Child Fetal Neonatal Ed, 93, pp.F257~260 (2008)
76. Palladini G, "Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis", Circulation, 107, pp.2440~2445 (2003)
77. Nikolaou NI, "Brain natriuretic peptide increases in septic patients without severe sepsis or shock", Eur J Intern Med, 18, pp.535~541 (2007)
78. Nakamura T, "Polymyxin Bimmobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic peptide and brain natriuretic Peptide levels in patients with septic shock", ASAIO J, 54, pp.210~213 (2008)
79. Christ-Crain M, "Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia", J Intern Med, 264, pp.166~176 (2008)
80. Kandil E, "B-type natriuretic peptide: a biomarker for the diagnosis and risk stratification of patients with septic shock", Arch Surg, 143, pp.242~246 (2008)
81. Varpula M, "Predictive value of N-terminal probrain natriuretic peptide in severe sepsis and septic shock", Crit Care Med, 35, pp.1277~1283 (2007)
82. Naganuma T, "The prognostic role of brain natriuretic peptides in hemodialysis patients", Am J Nephrol, 22, pp.437~444 (2002)
83. Goei D, "Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery", Am J Cardiol, 101, pp.122~126 (2008)
84. Tagore R, "Natriuretic peptides in chronic kidney disease", Clin J Am Soc Nephrol, 3, pp.1644~1651 (2008)
85. Biasioli S, "Significance of plasma B-type natriuretic peptide in hemodialysis patients: blood sample timing and comorbidity burden", ASAIO J, 53, pp.587~591 (2007)
86. Winkler K, "Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients", Eur Heart J (2008)
87. Yildiz R, "Brain natriuretic peptide and severity of disease in nonalcoholic cirrhotic patients", J Gastroenterol Hepatol, 20, pp.1115~1120 (2005)
88. Henriksen JH, "Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease", Gut, 52, pp.1511~1517 (2003)
89. Januzzi JL, "Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study", Crit Care, 10, pp.R37~ (2006)
90. Levitt JE, "Diagnostic utility of B-type natriuretic peptide in critically ill patients with pulmonary edema: a prospective cohort study", Crit Care, 12, pp.R3~ (2008)
91. Kia M, "The efficacy of B-type natriuretic peptide for early identification of blood loss in traumatic injury", Am J Surg, 191, pp.353~357 (2006)
92. Tobian AA, "N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload", Transfusion, 48, pp.1143~1150 (2008)
93. Meyer B, "N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients", Crit Care Med, 35, pp.2268~2273 (2007)
94. Schultz M, "N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states", Clin Endocrinol (Oxf), 60, pp.54~59 (2004)
95. Wei T, "B-type natriuretic peptide in patients with clinical hyperthyroidism", J Endocrinol Invest, 28, pp.8~11 (2005)
96. Ozmen B, "Serum Nterminal-pro-B-type natriuretic peptide (NT-pro-BNP) levels in hyperthyroidism and hypothyroidism", Endocr Res, 32, pp.1~8 (2007)
97. Anne M, "Neurohormonal activation in ischemic stroke: effects of acute phase disturbances on long-term mortality", Curr Neurovasc Res, 4, pp.170~175 (2007)
98. Giannakoulas G, "N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke", Angiology, 56, pp.723~730 (2005)
99. Nakagawa K, "Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke", Cerebrovasc Dis, 19, pp.157~164 (2005)
100. Di Angelantonio E, "Determinants of plasma levels of brain natriuretic peptide after acute ischemic stroke or TIA", J Neurol Sci, 260, pp.139~142 (2007)
101. Montaner J, "Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers", Stroke, 39, pp.2280~2287 (2008)
102. Anne M, "Neurohormonal activation in ischemic stroke: effects of acute phase disturbances on long-term mortality", Curr Neurovasc Res, 4, pp.170~175 (2007)
103. Berendes E, "Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage", Lancet, 349, pp.245~249 (1997)
104. Lu DC, "Cerebral salt wasting and elevated brain natriuretic peptide levels after traumatic brain injury: 2 case reports", Surg Neurol, 69, pp.226~229 (2008)
105. Stewart D, "B-type natriuretic peptide levels may be elevated in the critically injured trauma patient without congestive heart failure", J Trauma, 63, pp.747~750 (2007)
106. Tung PP, "Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage", Stroke, 36, pp.1567~1569 (2005)
107. Espiner EA, "The neuro-cardio-endocrine response to acute subarachnoid haemorrhage", Clin Endocrinol (Oxf), 56, pp.629~635 (2002)
108. Kirchhoff C, "Intrathecal and systemic concentration of NT-proBNP in patients with severe traumatic brain injury", J Neurotrauma, 23, pp.943~949 (2006)
109. Yarlagadda S, "Cardiovascular predictors of in-patient mortality after subarachnoid hemorrhage", Neurocrit Care, 5, pp.102~107 (2006)
110. Rauchenzauner M, "Brain-type natriuretic peptide secretion following febrile and afebrile seizures - a new marker in childhood epilepsy?", Epilepsia, 48, pp.101~106 (2007)
111. Obi T, "Secretion of natriuretic peptides caused by an epileptic attack", Acta Neurol Scand, 106, pp.225~228 (2002)
112. Davutoglu V, "Serum levels of NT-ProBNP as an early cardiac marker of carbon monoxide poisoning", Inhal Toxicol, 18, pp.155~158 (2006)

관련 논문AI추천